-
Mashup Score: 2
Dr. Ferguson sheds light on a national analysis evaluating the role of lymph node dissection in patients with high-risk UTUC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4
Liquid biopsy can benefit patients with UTUC by detecting rare events at higher incidences compared to tissue-based samples.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6
Rashid Sayyid and Zach Klaassen examine the published AUA guidelines for diagnosing and managing non-metastatic upper tract urothelial carcinoma. The conversation spans a wide array of topics including neoadjuvant and adjuvant chemotherapy, immunotherapy, surveillance, and survivorship. Dr. Sayyid focuses on the strong recommendation for cisplatin-based neoadjuvant chemotherapy, especially for…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Rashid Sayyid and Zach Klaassen examine the published AUA guidelines for diagnosing and managing non-metastatic upper tract urothelial carcinoma. The conversation spans a wide array of topics including neoadjuvant and adjuvant chemotherapy, immunotherapy, surveillance, and survivorship. Dr. Sayyid focuses on the strong recommendation for cisplatin-based neoadjuvant chemotherapy, especially for…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 11
Sam Chang interviews Jonathan Coleman and Wesley Yip. They delve into a Journal of Urology article detailing promising advancements in treating upper tract disease using photodynamic therapy, a non-invasive treatment method developed by Drs. Coleman and Yip. Their study seeks to decrease over-treatment of the disease, which often results in unnecessary kidney removal. Preliminary results show…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Rashid Sayyid and Zach Klaassen examine the published AUA guidelines for diagnosing and managing non-metastatic upper tract urothelial carcinoma. The conversation spans a wide array of topics including neoadjuvant and adjuvant chemotherapy, immunotherapy, surveillance, and survivorship. Dr. Sayyid focuses on the strong recommendation for cisplatin-based neoadjuvant chemotherapy, especially for…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Katie Murray joins Alicia Morgans to discuss reverse thermal mitomycin (JEMLYTO®) for primary chemoablation of upper tract urothelial carcinoma (UTUC) via a percutaneous nephrostomy tube. Based on results from the pivotal OLYMPUS trial, JELMYTO® is currently approved for low-grade UTUC. Dr. Murray speaks to two different methods of administration of the mitomycin gel that was allowed in this…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 11
Sam Chang interviews Jonathan Coleman and Wesley Yip. They delve into a Journal of Urology article detailing promising advancements in treating upper tract disease using photodynamic therapy, a non-invasive treatment method developed by Drs. Coleman and Yip. Their study seeks to decrease over-treatment of the disease, which often results in unnecessary kidney removal. Preliminary results show…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Katie Murray joins Alicia Morgans to discuss reverse thermal mitomycin (JEMLYTO®) for primary chemoablation of upper tract urothelial carcinoma (UTUC) via a percutaneous nephrostomy tube. Based on results from the pivotal OLYMPUS trial, JELMYTO® is currently approved for low-grade UTUC. Dr. Murray speaks to two different methods of administration of the mitomycin gel that was allowed in this…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Rashid Sayyid and Zach Klaassen examine the published AUA guidelines for diagnosing and managing non-metastatic upper tract urothelial carcinoma. The conversation spans a wide array of topics including neoadjuvant and adjuvant chemotherapy, immunotherapy, surveillance, and survivorship. Dr. Sayyid focuses on the strong recommendation for cisplatin-based neoadjuvant chemotherapy, especially for…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
👉 @JedUro1 sheds light on a national analysis evaluating the role of lymph node dissection in patients with high-risk #UTUC. 🎥 Watch Now: https://t.co/xNWYfix2It https://t.co/aPD2yyHlbJ